Global Insulin Delivery Devices Market is Predicted to Reach ~USD 53 Billion by 2032 | DelveInsight
The insulin delivery device market is primarily propelled by the growing incidence of diabetes, a shift toward home-based diabetes care, heightened awareness and patient education, advancements in product technology, and increased development efforts by leading industry players.
New York, USA, Oct. 07, 2025 (GLOBE NEWSWIRE) -- Global Insulin Delivery Devices Market is Predicted to Reach ~USD 53 Billion by 2032 | DelveInsight
The insulin delivery device market is primarily propelled by the growing incidence of diabetes, a shift toward home-based diabetes care, heightened awareness and patient education, advancements in product technology, and increased development efforts by leading industry players.
DelveInsight’s Insulin Delivery Devices Market Insights report provides the current and forecast market analysis, individual leading insulin delivery devices companies’ market shares, challenges, insulin delivery devices market drivers, barriers, trends, and key insulin delivery devices companies in the market.
Insulin Delivery Devices Market Summary
- The global insulin delivery devices market size is expected to increase from ~USD 36 billion in 2024 to ~USD 53 billion by 2032, reflecting strong and sustained growth.
- The global insulin delivery devices market is expected to grow at a CAGR of ~5% during the forecast period from 2025 to 2032.
- The leading companies working in the insulin delivery devices market include Becton, Dickinson and Company, Medtronic, Novo Nordisk A/S, Ypsomed Holding AG, Tandem Diabetes Care, Inc., Biocon Ltd., Eli Lilly and Company, Insulet Corporation, Abbott, Terumo Corporation, CeQur, EOFLOW CO., LTD, European Pharma Group BV, Roche, Sanofi, Hindustan Syringes & Medical Devices Ltd, Ocean (Hangzhou) Medical Technology Co Ltd, Owen Mumford, SOOIL Developments Co., Ltd, SUNGSHIM MEDICAL CO., LTD, and others.
- Among all the regions, North America is anticipated to register the fastest growth in the insulin delivery devices market during the forecast period.
- In the product type segment of the insulin delivery devices market, the insulin pens category accounted for the largest market share in 2024.
To read more about the latest highlights related to the insulin delivery devices market, get a snapshot of the key highlights entailed in the Global Insulin Delivery Devices Market Forecast Report
Key Factors Contributing to the Rise in Growth of the Insulin Delivery Devices Market
Increasing Prevalence of Diabetes
The rising number of diabetes cases worldwide, particularly type 1 and type 2 diabetes, is a primary driver. As more patients require regular insulin administration, demand for efficient and convenient delivery devices, such as insulin pens, pumps, and connected devices, continues to grow.
Technological Advancements in Delivery Devices
Innovation in insulin delivery technology, including smart insulin pens, continuous glucose monitoring (CGM)-integrated pumps, and automated insulin delivery systems, has enhanced dosing accuracy, improved patient convenience, and increased adherence. This encourages both physicians and patients to adopt these advanced devices.
Focus on Patient-Centric Care
Healthcare providers are increasingly emphasizing personalized treatment plans to enhance quality of life and reduce complications. Insulin delivery devices that simplify administration, reduce pain, and allow patients to support market growth prefer flexible dosing.
Rising Awareness and Education
Increased awareness of diabetes management and the importance of proper insulin administration drives adoption. Educational campaigns, patient support programs, and digital health initiatives have helped patients understand the benefits of modern delivery devices.
Supportive Healthcare Infrastructure and Reimbursement Policies
Developed regions with robust healthcare systems, insurance coverage, and reimbursement for diabetes management tools encourage the adoption of insulin delivery devices. Government initiatives to reduce the diabetes burden further support market expansion.
Growing Adoption of Digital Health and Connected Devices
The integration of insulin delivery devices with mobile apps and wearable technologies enables real-time monitoring and personalized feedback. The trend toward connected care enhances patient engagement and adherence, boosting device uptake.
Shift Towards Minimally Invasive and Pain-Free Options
Patients increasingly prefer devices that are user-friendly, minimally invasive, and less painful than traditional syringes. This preference drives the development and adoption of pen devices and patch pumps.
Get a sneak peek at the insulin delivery devices market dynamics @ Insulin Delivery Devices Market Trends
Regional Insulin Delivery Devices Market Insights
North America led the global insulin delivery devices market, commanding a significant 36% share in 2024. This dominance is fueled by a high prevalence of diabetes, a well-established healthcare infrastructure, and a strong inclination toward adopting innovative medical technologies.
Europe also plays a major role in driving the insulin delivery devices market, supported by its advanced healthcare systems, increasing diabetes rates, and a preference for sophisticated, connected technologies. The region is a hub for innovation, with leading companies regularly introducing new devices and expanding the applications of existing ones. For instance, in July 2025, Medtronic plc received CE Mark approval to broaden the use of its MiniMed™ 780G system. This approval enables the automated insulin delivery (AID) system to serve a broader range of patients, including children as young as two, pregnant women, and individuals with insulin-requiring Type 2 diabetes. Backed by robust clinical evidence, this expansion underscores Europe’s commitment to making advanced technologies accessible to diverse patient groups, reinforcing its role as a key growth driver in the global market.
The Asia-Pacific region is rapidly emerging as a significant contributor to market growth, driven by the increasing prevalence of diabetes resulting from urbanization, sedentary lifestyles, and changing dietary patterns. Highly populated countries such as China and India are at the forefront of this trend, generating substantial demand for convenient and effective insulin delivery solutions, including pens, pumps, and smart devices.
To know more about why North America is leading the market growth in the insulin delivery devices market, get a snapshot of the Insulin Delivery Devices Market Share
Recent Developmental Activities in the Insulin Delivery Devices Market
- In July 2025, Medtronic plc announced that it had received the CE Mark in Europe to expand the indications of the MiniMed 780G system for individuals aged 2 years and older, during pregnancy, and for those with type 2 insulin-requiring diabetes.
- In May 2025, GO-Pen ApS received FDA 510(k) clearance for the GO-PEN®, a user-filled insulin pen compatible with standard insulin vials, providing an affordable alternative to traditional disposable pens.
- In April 2025, Dexcom received FDA clearance for the G7 15-Day sensor, which boasts extended wear time and enhanced accuracy for diabetes management.
What are Insulin Delivery Devices?
Insulin delivery devices have become a cornerstone in diabetes management, providing patients with efficient and precise methods for administering insulin. These devices include traditional syringes, insulin pens, insulin pumps, and emerging smart devices that integrate digital technology for enhanced dosing accuracy. Insulin pens, for example, offer convenience, portability, and ease of use compared to syringes, while insulin pumps enable continuous subcutaneous insulin infusion, closely mimicking the body’s natural insulin release and providing better glycemic control. Recent advancements have also introduced smart pens and connected devices that track doses, provide reminders, and sync with mobile applications, improving adherence and patient outcomes.
| Insulin Delivery Devices Market Report Metrics | Details |
| Coverage | Global |
| Study Period | 2022–2032 |
| Insulin Delivery Devices Market CAGR | ~5% |
| Insulin Delivery Devices Market Size by 2032 | ~USD 53 Billion |
| Key Insulin Delivery Devices Companies | Becton, Dickinson and Company, Medtronic, Novo Nordisk A/S, Ypsomed Holding AG, Tandem Diabetes Care, Inc., Biocon Ltd., Eli Lilly and Company, Insulet Corporation, Abbott, Terumo Corporation, CeQur, EOFLOW CO., LTD, European Pharma Group BV, Roche, Sanofi, Hindustan Syringes & Medical Devices Ltd, Ocean (Hangzhou) Medical Technology Co Ltd, Owen Mumford, SOOIL Developments Co., Ltd, SUNGSHIM MEDICAL CO., LTD, and others |
Insulin Delivery Devices Market Assessment
-
Insulin Delivery Devices Market Segmentation
- Insulin Delivery Devices Market Segmentation By Product Type: Insulin Syringes, Insulin Pens (Reusable Insulin Pens and Disposable Insulin Pens), Insulin Pumps (Tethered/External Pumps and Patch Pumps), Insulin Injectors, and Others
- Insulin Delivery Devices Market Segmentation By End-User: Homecare Settings, Diabetes Centers, Hospitals, and Others
- Insulin Delivery Devices Market Segmentation By Geography: North America, Europe, Asia-Pacific, and Rest of World
- Porter’s Five Forces Analysis, Product Profiles, Case Studies, KOL’s Views, Analyst’s View
Which MedTech key players in the insulin delivery devices market are set to emerge as the trendsetter explore @ Insulin Delivery Devices Market Analysis
Table of Contents
| 1 | Insulin Delivery Devices Market Report Introduction |
| 2 | Insulin Delivery Devices Market Executive Summary |
| 3 | Competitive Landscape |
| 4 | Regulatory Analysis |
| 5 | Insulin Delivery Devices Market Key Factors Analysis |
| 6 | Insulin Delivery Devices Market Porter’s Five Forces Analysis |
| 7 | Insulin Delivery Devices Market Layout |
| 8 | Insulin Delivery Devices Market Company and Product Profiles |
| 9 | KOL Views |
| 10 | Project Approach |
| 11 | About DelveInsight |
| 12 | Disclaimer & Contact Us |
Interested in knowing the newer insulin delivery devices? Click to get a snapshot of the Types of Insulin Delivery Devices
Related Reports
Smart Insulin Pens Market Insights, Competitive Landscape, and Market Forecast – 2032 report deliver an in-depth understanding of the market trends, market drivers, market barriers, and key smart insulin pens companies, including Emperra GmbH E-Health Technologies, Jiangsu Deflu Medical Device Co. Ltd., Medtronic, Novo Nordisk A/S, Pendiq., Sanofi, Berlin-Chemie, Bigfoot Biomedical, Digital Medics Pty Ltd., Eli Lilly and Company, Ypsomed, Dexcom, Inc., among others.
Insulin Pens Market Insights, Competitive Landscape, and Market Forecast – 2032 report deliver an in-depth understanding of the market trends, market drivers, market barriers, and key insulin pens companies, including Novo Nordisk A/S, Owen Mumford Ltd, Sanofi Diabetes, Merck Sharp & Dohme Corp., Insulet Corporation., Biocon Ltd., B. Braun Melsungen AG, Eli Lilly and Co., DIABETIC PROMOTIONS., Ypsomed Logo, Medtronic., BERLIN-CHEMIE AG, pendiq., Emperra GmbH E-Health Technologies, Digital Medics Pty Ltd., delfu-medical, Diamesco Co. Ltd. e, Becton, Dickinson and Company., Vansea Medical, Montmédand, among others.
Insulin Infusion Pumps Market Insights, Competitive Landscape, and Market Forecast – 2032 report deliver an in-depth understanding of the market trends, market drivers, market barriers, and key insulin infusion pumps companies, including F. Hoffmann-La Roche Ltd, Medtronic, Medtrum Technologies Inc., A. Menarini Diagnostic’s s.r.l., IA Collaborative Holdings, LLC, Apex Medical, Insulet Corporation, Ascensia Diabetes Care Holdings AG, Ypsomed AG, Tandem Diabetes Care, Inc., ICU Medical, Inc., SOOIL Developments Co., Ltd., MicroPort Scientific Corporation, Microtec Medical, among others.
Prefilled Syringes Market Insights, Competitive Landscape, and Market Forecast – 2032 report deliver an in-depth understanding of the market trends, market drivers, market barriers, and key prefilled syringes companies, including BD, Nipro Corporation, Taisei Kako Co., Ltd., Terumo Corporation, SCHOTT Pharma AG & Co. KGaA, Gerresheimer AG, Johnson and Johnson Services, Inc., Dali Medical Devices, Stevanato Groupand, Credence MedSystems, Inc., Baxter, MAEDA INDUSTRY Co., Ltd., MedXL, Inc., Sanofi, Sandoz AG, Pfizer Inc., B. Braun Melsungen AG, Novartis AG, Fresenius SE & Co. KGaA, Cardinal Health, among others.
DelveInsight’s Pharma Competitive Intelligence Service: Through its CI solutions, DelveInsight provides its clients with real-time and actionable intelligence on their competitors and markets of interest to keep them stay ahead of the competition by providing insights into the latest therapeutic area-specific/indication-specific market trends, in emerging drugs, and competitive strategies. These services are tailored to the specific needs of each client and are delivered through a combination of reports, dashboards, and interactive presentations, enabling clients to make informed decisions, mitigate risks, and identify opportunities for growth and expansion.
Other Business Pharmaceutical Consulting Services
Healthcare Conference Coverage
Discover how a mid-pharma client gained a level of confidence in their soon-to-be partner for manufacturing their therapeutics by downloading our Due Diligence Case Study
About DelveInsight
DelveInsight is a leading Business Consultant, and Market Research firm focused exclusively on life sciences. It supports pharma companies by providing comprehensive end-to-end solutions to improve their performance.
Contact Us Shruti Thakur info@delveinsight.com +14699457679
Legal Disclaimer:
EIN Presswire provides this news content "as is" without warranty of any kind. We do not accept any responsibility or liability for the accuracy, content, images, videos, licenses, completeness, legality, or reliability of the information contained in this article. If you have any complaints or copyright issues related to this article, kindly contact the author above.
